Targeting Asymptomatic Bacteriuria in Antimicrobial Stewardship: the Role of the Microbiology Laboratory

被引:14
|
作者
Wiley, Zanthia [1 ]
Jacob, Jesse T. [1 ]
Burd, Eileen M. [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
asymptomatic; asymptomatic bacteriuria; bacteriuria; urine culture; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; OVERTREATMENT; PREVALENCE; MANAGEMENT; CULTURE; UPDATE; MEN;
D O I
10.1128/JCM.00518-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This minireview focuses on the microbiologic evaluation of patients with asymptomatic bacteriuria, as well as indications for antibiotic treatment. Asymptomatic bacteriuria is defined as two consecutive voided specimens (preferably within 2 weeks) with the same bacterial species, isolated in quantitative counts of >= 10(5) CFU/ml in women, including pregnant women; a single voided urine specimen with one bacterial species isolated in a quantitative count >= 10(5) CFU/ml in men; and a single catheterized urine specimen with one or more bacterial species isolated in a quantitative count of >10(5) CFU/ml in either women or men (or >10(2) CFU/ml of a single bacterial species from a single catheterized urine specimen). Any urine specimen with >= 10(4) CFU/ml group B Streptococcus is significant for asymptomatic bacteriuria in a pregnant woman. Asymptomatic bacteriuria occurs, irrespective of pyuria, in the absence of signs or symptoms of a urinary tract infection. The two groups with the best evidence of adverse outcomes in the setting of untreated asymptomatic bacteriuria include pregnant women and patients who undergo urologic procedures with risk of mucosal injury. Screening and treatment of asymptomatic bacteriuria is not recommended in the following patient populations: pediatric patients, healthy nonpregnant women, older patients in the inpatient or outpatient setting, diabetic patients, patients with an indwelling urethral catheter, patients with impaired voiding following spinal cord injury, patients undergoing nonurologic surgeries, and nonrenal solid-organ transplant recipients. Renal transplant recipients beyond 1 month posttransplant should not undergo screening and treatment for asymptomatic bacteriuria. There is insufficient evidence to recommend for or against screening of renal transplant recipients within 1 month, patients with high-risk neutropenia, or patients with indwelling catheters at the time of catheter removal. Unwarranted antibiotics place patients at increased risk of adverse effects (including Clostridioides difficile diarrhea) and contribute to antibiotic resistance. Methods to reduce unnecessary screening for and treatment of asymptomatic bacteriuria aid in antibiotic stewardship.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Impact of an Antimicrobial Stewardship Program Pharmacist During Microbiology Rounds
    Sapozhnikov, Julia
    Huang, Angela
    Revolinski, Sara
    Ledeboer, Nathan A.
    Buchan, Blake W.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (03) : 455 - 460
  • [32] Antimicrobial Treatment of Asymptomatic Bacteriuria in Noncatheterized Adults: A Systematic Review
    Dull, Ryan B.
    Friedman, Stacey K.
    Risoldi, Zara M.
    Rice, Eric C.
    Starlin, Richard C.
    Destache, Christopher J.
    [J]. PHARMACOTHERAPY, 2014, 34 (09): : 941 - 960
  • [33] Antimicrobial Stewardship: The Role of the Patient
    Tola Ewers
    Mary Jo Knobloch
    Nasia Safdar
    [J]. Current Treatment Options in Infectious Diseases, 2017, 9 (1) : 92 - 103
  • [34] The Pharmacist's Role in Managing Asymptomatic Bacteriuria
    Holmes, Madison
    Renaud, Amy
    Javanmardi, Cameron
    Carter, Chenita
    Parrish, Raevyn
    Allen, Unique
    Thervil, Willineza
    [J]. US PHARMACIST, 2023, 48 (04) : 13 - 20
  • [35] Antimicrobial use for asymptomatic bacteriuria-First, do no harm
    Shpunt, Yana
    Estrin, Inna
    Levi, Yossef
    Saadon, Hodaya
    Ben-Yossef, Galit
    Goldshtein, Lili
    Klafter, Dan
    Zilberman-Itskovich, Shani
    Ben-David, Debby
    Katz, David E.
    Lazarovitch, Tsillia
    Zaidenstein, Ronit
    Marchaim, Dror
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (01): : 37 - 42
  • [36] The role of education in antimicrobial stewardship
    Satterfield, J.
    Miesner, A. R.
    Percival, K. M.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2020, 105 (02) : 130 - 141
  • [37] Role of the Pharmacist in Antimicrobial Stewardship
    Parente, Diane M.
    Morton, Jacob
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (05) : 929 - +
  • [38] Role of Technology in Antimicrobial Stewardship
    Bremmer, Derek N.
    Trienski, Tamara L.
    Walsh, Thomas L.
    Moffa, Matthew A.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (05) : 955 - +
  • [39] The Role of Pharmacists in Antimicrobial Stewardship
    Muraki, Yuichi
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (04): : 557 - 564
  • [40] Is there a role for antimicrobial stewardship in bronchiectasis?
    Gassiep, I.
    Chaudhuri, A.
    [J]. CHRONIC RESPIRATORY DISEASE, 2015, 12 (03) : 274 - 275